The effect of oral immunotherapy for food allergy
Not Applicable
Recruiting
- Conditions
- food allergy
- Registration Number
- JPRN-UMIN000029251
- Lead Sponsor
- Saitama city hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with poorly controlled asthma or atopic dermatitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients who achieved target dose after 1, 2 and 3 years of treatment
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie oral immunotherapy for food allergy in JPRN-UMIN000029251?
How does oral immunotherapy compare to sublingual immunotherapy in treating IgE-mediated food allergies?
What biomarkers are associated with successful oral immunotherapy outcomes in food allergy patients?
What are the potential adverse events of oral immunotherapy for food allergy and their management strategies?
Are there combination therapies with oral immunotherapy that enhance desensitization in food allergy treatment?